Peptide record

TPDB93206

Angiopep-2 Blood-Brain Barrier Cell-penetrating Peptides modified_plain modified
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB93206
Angiopep-2
Blood-Brain Barrier Cell-penetrating Peptides
Delivery and barrier-penetrating peptides
B3Pred BBPpredict Peptipedia CPPsite3.0
modified_plain
Yes
A 19-aa modified multi-activity (Blood-Brain Barrier and Cell-penetrating Peptides) peptide sequence curated from B3Pred, BBPpredict, Peptipedia, and other sources, with an available 3D structural model.
Chemical: Conjugated with Tratuzumab
Sequence
TFFYGGSRGKRNNFKTEEY
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
19 reviewed residue count
Conjugated with Tratuzumab Activity
Linear Activity
ThrPhePheTyrGlyGlySerArgGlyLysArgAsnAsnPheLysThrGluGluTyr Activity
Evidence Records 2 records
Evidence 1 Activity

Activity

Blood-Brain Barrier

Assay & Model

10mg/Kg
Fluoroscent screening by FITC labbled peptide maass in brain tissue
Significant fluoroscdnt observed in brain tissue
Breast cancer metastasis

Source & Reference

NA
B3Pdb

Other

Intravenous
Evidence 2 Activity

Activity

Blood-Brain Barrier

Assay & Model

6 ml/kg
In situ brain perfusion assay
10 time increase of Mab as compared to control in brain tissue
Breast cancer metastasis

Source & Reference

NA
B3Pdb

Other

Intravenous
Additional Detail Fields 1 fields
Intravenous